Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfa

Hepatology Research

Volumn 35, Issue 4, 2006, Pages 256-262

  Bain, Vincent G ^a   Yoshida, Eric M ^b   Kaita, Kelly D ^c   Swain, Mark G ^d   Heathcote, E Jenny ^e   Garcia, Andy ^f   Moore, Paul A ^f   Yu, Ren ^f   McHutchison, John G ^g   Subramanian, G Mani ^f  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f GLAXOSMITHKLINE   (United States)

^g DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Albumin interferon alfa; Interferon specific gene; TaqMan PCR

Indexed keywords

ALBUMIN ALPHA INTERFERON; ALPHA INTERFERON; INTERFERON; RIBAVIRIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; GENE EXPRESSION; GENE INDUCTION; GENOTYPE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INDIVIDUALITY; MALE; MOLECULAR DYNAMICS; MULTICENTER STUDY; OBSERVATIONAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 33746523062     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2006.04.005     Document Type: Article

References (14)

1. Tilg H. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 112 (1997) 1017-1021
2. Feld J.J., and Hoofnagle J.H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436 (2005) 967-972
3. Ji X., Cheung R., Cooper S., et al. Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology 37 (2003) 610-621
4. Taylor M.W., Grosse W.M., Schaley J.E., et al. Global effect of PEG-IFN-α and ribavirin on gene expression in PBMC in vitro. J Interferon Cytokine Res 24 (2004) 107-118
5. Balan V., Nelson D., Sulkowski M., et al. Molecular profiles of drug response in HCV infected patients during the first 4 weeks of therapy for chronic hepatitis C virus with pegylated interferon containing regimens or Albuferon. Hepatology 38 Suppl. 1:630A (2003) [Abstract 984]
6. Osborn B.L., Olsen H.S., Nardelli B., et al. Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-α fusion protein in cynomolgus monkeys. J Pharmacol Exp Ther 303 2 (2002) 540-548
7. Balan V., Sulkowski M., Nelson D., et al. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy. Antivir Ther 11 1 (2006) 35-45
8. Bain V.G., Kaita K.D., Yoshida E.M., et al. A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients. J Hepatol 44 4 (2006) 671-678
9. Der S.D., Zhou A., Williams B.R.G., et al. Identification of genes differentially regulated by interferon or using oligonucleotide arrays. Proc Natl Acad Sci USA 95 (1998) 15623-15628
10. Hayashi J., Stoyanova R., and Seeger C. The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon. Virology 335 2 (2005) 264-275
11. Zhu H., Zhao H., Collins C.D., et al. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 37 5 (2003) 1180-1188
12. Honda K., Yanai H., Negishi H., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 435 (2005) 772-777
13. Knapp S., Yee L.J., Frodsham A.J., et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun 4 6 (2003) 411-419
14. Chen L., Borozan I., Feld J., et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128 5 (2005) 1437-1444